BAYRY Recent News Today's Top Biotech Stories: Am
Post# of 8
Posted On: 03/02/2014 11:02:43 PM
BAYRY Recent News
Today's Top Biotech Stories: Ampio Pharmaceuticals, Auxilium Pharmaceuticals, Bayer, and Medivation Motley Fool - Fri Feb 28, 8:15AM CST
Concise Analysis of the International Bisphenol A Market M2 - Fri Feb 28, 5:41AM CST
Bayer reports $4.35 billion full-year net profit AP - Fri Feb 28, 3:01AM CST
Regeneron Pipeline Could Be The Big Story In 2014 at Investor's Business Daily - Thu Feb 27, 5:30PM CST
Global Postmenopausal Vaginal Atrophy Drug Forecast and Market Analysis to 2022 M2 - Thu Feb 27, 5:10AM CST
Global Agrochemicals Market Report 2014 - Forecast to 2018: Type, Fertilizer Type, Pesticide Type, & Sub-Types M2 - Wed Feb 26, 8:58AM CST
Directory of Arts Foundations 2013 M2 - Wed Feb 26, 2:24AM CST
No Looking Back for Regeneron's Eylea - Analyst Blog Zacks Investment Research - Tue Feb 25, 10:08AM CST
Bayer Progresses with Stivarga - Analyst Blog Zacks Investment Research - Fri Feb 21, 4:00PM CST
OncoMed Commences Study on OMP-54F28 - Analyst Blog Zacks Investment Research - Fri Feb 21, 3:50PM CST
Today's Top Biotech Stories: Ampio Pharmaceuticals, Auxilium Pharmaceuticals, Bayer, and Medivation Motley Fool - Fri Feb 28, 8:15AM CST
Concise Analysis of the International Bisphenol A Market M2 - Fri Feb 28, 5:41AM CST
Bayer reports $4.35 billion full-year net profit AP - Fri Feb 28, 3:01AM CST
Regeneron Pipeline Could Be The Big Story In 2014 at Investor's Business Daily - Thu Feb 27, 5:30PM CST
Global Postmenopausal Vaginal Atrophy Drug Forecast and Market Analysis to 2022 M2 - Thu Feb 27, 5:10AM CST
Global Agrochemicals Market Report 2014 - Forecast to 2018: Type, Fertilizer Type, Pesticide Type, & Sub-Types M2 - Wed Feb 26, 8:58AM CST
Directory of Arts Foundations 2013 M2 - Wed Feb 26, 2:24AM CST
No Looking Back for Regeneron's Eylea - Analyst Blog Zacks Investment Research - Tue Feb 25, 10:08AM CST
Bayer Progresses with Stivarga - Analyst Blog Zacks Investment Research - Fri Feb 21, 4:00PM CST
OncoMed Commences Study on OMP-54F28 - Analyst Blog Zacks Investment Research - Fri Feb 21, 3:50PM CST
(0)
(0)